Muscular and plasma markers for early identification of frailty and sarcopenia states in people with HIV.
Por:
Hernández-Sánchez D, Satorra P, Martínez A, Puig J, González S, Rupert A, Monté-Rubio G, Echeverria P, Bonjoch A, Ferrer-Arbaizar J, Tebe C, Puig J, Sereti I and Negredo E
Publicada:
1 feb 2026
Ahead of Print:
6 oct 2025
Resumen:
BACKGROUND: Healthcare needs of older people with HIV (PWH) are changing given the higher incidence and earlier onset of age-related conditions compared to people without HIV (PWoH). This emphasizes a need for novel prognostic markers that allow identification of earlier stages of functional deterioration and prevent its advancement. METHODS: With this aim, we compared muscular imaging markers (whole-body MRI) and plasma biomarkers (irisin, myostatin, and coenzyme Q10) between PWH ( n = 50) and PWoH ( n = 25) aged 50 or older, and their associations with clinical conditions. Spearman's rank correlation coefficient was estimated and presented in correlation matrices for the most relevant groups of study variables with intramuscular fat fraction and plasma biomarkers. The distribution of plasma biomarkers and intramuscular fat fraction values was presented graphically in boxplots as a function of the functional test category. The Wilcoxon rank sum test was performed for comparisons, and P values are presented in tables. Raw and adjusted logistic models were fitted, and the estimated odds ratios are presented in tables. Adjusted variables were age, sex, and HIV status group. RESULTS: PWH exhibited greater deterioration, including lower autonomy, higher rates of prefrailty/frailty and malnutrition, and reduced bone mineral density. Mild to moderate dependency (Barthel) was observed only in PWH (18.4%), with 50% of PWH at risk of dependency (Barber) compared to 25% in PWoH. Prefrailty (Fried) was more prevalent in PWH (46%) than PWoH (28%), and frailty was exclusive to PWH (14%). PWH also had higher plasma myostatin and lower irisin levels. Lower intramuscular fat content was associated with malnutrition and dependency, while total intramuscular fat was positively correlated with time living with HIV and negatively with CD4 + T-cell count. Higher coenzyme Q10 levels were seen in states of poorer health, particularly frailty [Fried, Short Physical Performance Battery (SPPB)], while higher irisin levels were observed together with frailty (Fried) and dependency (Barthel, Barber). For all adjusted models, HIV status strongly influenced Fried, Barthel, and SPPB functional scores. CONCLUSION: These findings underscore the need for further assessment of these biomarkers for their diagnostic and predictive potential in aging-related conditions such as frailty in PWH.
Filiaciones:
:
Fundació Lluita contra les Infeccions
Germans Trias i Pujol Hospital, Universitat Autònoma de Barcelona, Badalona, Catalonia
Satorra P:
Biostatistics Support and Research Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain
Martínez A:
Fundació Lluita contra les Infeccions
:
Fundació Lluita contra les Infeccions
Germans Trias i Pujol Hospital, Universitat Autònoma de Barcelona, Badalona, Catalonia
González S:
Fundació Lluita contra les Infeccions
Rupert A:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA
Monté-Rubio G:
Comparative Medicine & Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), Badalona
Echeverria P:
Fundació Lluita contra les Infeccions
Germans Trias i Pujol Hospital, Universitat Autònoma de Barcelona, Badalona, Catalonia
:
Germans Trias i Pujol Hospital, Universitat Autònoma de Barcelona, Badalona, Catalonia
Ferrer-Arbaizar J:
Fundació Lluita contra les Infeccions
:
Biostatistics Support and Research Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain
Puig J:
Universitat de Vic - Universidad Central de Catalunya (UVIC-UCC), Vic
Sereti I:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA
:
Fundació Lluita contra les Infeccions
Germans Trias i Pujol Hospital, Universitat Autònoma de Barcelona, Badalona, Catalonia
Department of Radiology (CDI) and IDIBAPS, Hospital Clínic de Barcelona, Barcelona
Universitat de Vic - Universidad Central de Catalunya (UVIC-UCC), Vic
CIBERINFEC. Madrid, Spain
|